NFKB1 and osteoarthritis: Schisandrin B or psoralen ameliorated chondrocyte inflammation and osteoarthritis, oxidative stress injury, and DSS-induced colitis via suppression of the NF-κB/MAPK signaling pathways, followed by decreased inflammatory cytokines (Liu et al., 2015a,b; Li et al., 2017; Zhu et al., 2017; Ran et al., 2018).